Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.

Get IMNM alerts

About Jack Higgins

Immunome Inc. reported in an 8-K filed October 4, 2023 that Jack Higgins was appointed Chief Scientific Officer, effective October 2, 2023. The proxy statement of Immunome Inc. reports total compensation of $1,840,854 for Jack Higgins in fiscal 2023, including a base salary of $107,916. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.

“Immediately following the effective time of the Merger, Immunome's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Immunome Inc. Form 8-K, filed October 4, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Immunome Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Immunome Inc. (IMNM) $107,916 $1,840,854

Recent activity